Data / Form D filings / Aevum Longevity Corp.
Aevum Longevity Corp.: Form D filing
Aevum Longevity Corp., a pharmaceuticals company in Vancouver, British Columbia, Canada, filed a Form D with the SEC in 2025. The latest, on July 9, 2025, reports $2,251 sold of a $2,251 offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2501 - 550 BURRARD STREET, Vancouver, British Columbia, Canada, V6C 2
- Phone
- (604) 868-1669
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2076042
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 9, 2025 | New notice | $2,251 | $2,251 | 4 | Jul 7, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Amandeep Gill | Director | |
| Robert Payment | Director |
Every Form D from the week of Jul 7, 2025 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Aevum Longevity Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.